219 related articles for article (PubMed ID: 12194998)
1. Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate.
Pollock W; Clarke K; Gallagher K; Hall J; Luckhurst E; McEvoy R; Melny J; Neil J; Nikoloutsopoulos A; Thompson T; Trevisin M; Savige J
J Clin Pathol; 2002 Sep; 55(9):680-3. PubMed ID: 12194998
[TBL] [Abstract][Full Text] [Related]
2. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
3. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
Paspaliaris B; Pamio M; Savige J
J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
Pollock W; Jovanovich S; Savige J
J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
[TBL] [Abstract][Full Text] [Related]
5. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
Savige J; Trevisin M; Pollock W
J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
[TBL] [Abstract][Full Text] [Related]
6. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase.
Pollock W; Dunster K; Rolland JM; Koh H; Savige J
Pathology; 1999 Feb; 31(1):38-43. PubMed ID: 10212921
[TBL] [Abstract][Full Text] [Related]
7. A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
Lin MW; Silvestrini RA; Culican S; Campbell D; Fulcher DA
Am J Clin Pathol; 2014 Sep; 142(3):325-30. PubMed ID: 25125622
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli and Proteus mirabilis inhibit the perinuclear but not the circulating antineutrophil cytoplasmic antibody reaction.
Yang P; Danielsson D; Järnerot G
Scand J Gastroenterol; 1998 May; 33(5):529-34. PubMed ID: 9648994
[TBL] [Abstract][Full Text] [Related]
9. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).
Savige J; Gillis D; Benson E; Davies D; Esnault V; Falk RJ; Hagen EC; Jayne D; Jennette JC; Paspaliaris B; Pollock W; Pusey C; Savage CO; Silvestrini R; van der Woude F; Wieslander J; Wiik A
Am J Clin Pathol; 1999 Apr; 111(4):507-13. PubMed ID: 10191771
[TBL] [Abstract][Full Text] [Related]
10. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
Avery TY; Bons J; van Paassen P; Damoiseaux J
Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
[TBL] [Abstract][Full Text] [Related]
14. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
[TBL] [Abstract][Full Text] [Related]
15. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
Fu HL; Hsu TC; Chang CC; Tsay GJ
J Formos Med Assoc; 2001 Jan; 100(1):35-9. PubMed ID: 11265258
[TBL] [Abstract][Full Text] [Related]
16. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
Yang P
J Clin Pathol; 1997 Aug; 50(8):677-80. PubMed ID: 9301553
[TBL] [Abstract][Full Text] [Related]
18. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
[TBL] [Abstract][Full Text] [Related]
19. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
20. A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies.
Shovman O; Agmon-Levin N; Gilburd B; Martins T; Petzold A; Matthias T; Shoenfeld Y
Immunol Res; 2015 Feb; 61(1-2):135-40. PubMed ID: 25403695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
